Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
Notable Analyst Rating Changes 05/05: S, CAb, ERTS, AMMD Upgraded; ITMN, MRK, NWSA, MYGN Downgraded
-
Piper Jaffray Downgrades Myriad Genetics (MYGN) to Neutral; Using A Garden Trowel To Dig Out Of A Crater
-
Notable Analyst Rating Changes 1/12: PG, MGM, DPZ, CMA, QLGC, WGOV Upgraded; CL, GPS, NWY, PMCS, LEAP, MYGN Downgraded
-
Piper Jaffray Positive On Med Tech Stocks In '10
-
Unusual 11 Mid-Day Movers 7/1: OSK, BORL, UIS, SDTH Higher; BEAT, FRPT, RPRX, SPAR Lower
-
David Moenning's Daily State of the Markets: 7/1
-
Piper Jaffray Initiates Coverage on Myriad Pharmaceuticals (MYRX) with an Underweight; Pipeline Lacks Sufficient Data
-
Piper Jaffray Transfers Coverage on Myriad Genetics (MYGN) to Overweight; Attractive Opportunity At Present Levels
-
Morning Movers 5/5: CALL, CTIC, ATRC, PEGA, ACAD Higher; HLIT, HOLX, DW, PQ, MYGN Lower
-
Piper Jaffray Calls Myriad Genetics (MYGN) A Top 2009 Pick
-
Piper Jaffray Reiterates a 'Buy' on Myriad Genetics (MYGN), Raises Price Target and Earnings Estimates
-
Piper Jaffray Bumps Price Target on Myriad Genetics (MYGN) to $74
-
Piper Jaffray Would Be Buyers of Myriad Genetics (MYGN) On Today's Sell-Off
